Financials
- Market Capitalization 716.17 M
- Employee 61
- Founded 2006
- CEO N/A
- Website www.zevra.com
- Headquarter Delaware, United States
- FIGI BBG0026ZG1F5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
15.26
Relación precio/flujo de caja
6.21
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2668 | GYRE Gyre Therapeutics, Inc. - Common Stock | 6.47 USD | -1.52% | -3.58% | +11.55% | -21.67% | 721.47 M USD | ||
| 2675 | ASMB Assembly Biosciences, Inc. - Common Stock | 35.18 USD | +4.61% | -0.57% | +39.99% | +19.56% | 716.29 M USD | ||
| 2684 | BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 8.82 USD | +0.23% | -5.77% | +8.35% | -8.12% | 707.14 M USD | ||
| 2694 | SLN Silence Therapeutics Plc - American Depository Share | 14.74 USD | +8.94% | +7.75% | +39.98% | +207.08% | 696.42 M USD |